Did you read the recent headlines about the newly released study concluding that even after women (in the study) completed five years of hormone therapy, their recurrence risk continued for twenty years and likely beyond? The implication is that women diagnosed with early stage, hormone-positive breast cancer and who are taking hormone-blocking drugs, should strongly …
Research
When your advocacy efforts revolve around breast cancer, hurt happens. When your advocacy efforts often focus specifically on metastatic breast cancer, hurt is inevitable. Not only is it inevitable, hurt happens again and again and again. The reason is obvious, or should be by now. Too many keep dying from metastatic breast cancer. Too many. …
It’s been nine years since my mother died from metastatic breast cancer. She was diagnosed with early stage, ER+ breast cancer in 2004. Her cancer metastasized to her liver and probably her bones, too, in 2007. She died a few months later on March 6, 2008. Statistics say, following a metastatic diagnosis, the median survival …
Have you heard about the relatively new It’s About Time initiative which was started last fall to raise awareness about metastatic breast cancer? Recently the campaign launched an additional effort focused on advocating for more research specific to metastatic breast cancer. There will be a congressional caucus in mid-May focused on women’s issues. The It’s …
Edit Note: Updated on May 8, 2019. Read my updates at the end of this post. May has evolved into Breast Cancer Awareness Month part 2. Or maybe it’s part 1 since May comes before October. Regardless, May ushers in the season of races. I first wrote about my discomfort with too much racing, not …